Cargando…
Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial
BACKGROUND: Epistaxis is the most common emergent consultation to otolaryngology-head & neck surgery (OHNS) and with 60% of the population having experienced an episode and 1.6 in 10,000 requiring hospitalization in their lifetime. In preliminary studies Floseal® (Baxter, USA) Hemostatic Matrix...
Autores principales: | Murray, Scott, Mendez, Adrian, Hopkins, Alexander, El-Hakim, Hamdy, Jeffery, Caroline C., Côté, David W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759868/ https://www.ncbi.nlm.nih.gov/pubmed/29310703 http://dx.doi.org/10.1186/s40463-017-0248-5 |
Ejemplares similares
-
Efficacy of a topical gelatin-thrombin hemostatic matrix, FLOSEAL(®), in intracranial tumor resection
por: Kamamoto, Dai, et al.
Publicado: (2020) -
Surgical treatment of nasal packing refractory epistaxis
por: Winckler Rabelo, Fábio Augusto, et al.
Publicado: (2015) -
P19 An audit to improve ENT SHO confidence in using Floseal in the management of epistaxis
por: Ringrose, T, et al.
Publicado: (2021) -
Is the use of hemostatic matrix (Floseal) and alkylene oxide copolymer (Ostene) safe in spinal laminectomies? Peridural fibrosis assessment
por: Gurcan, Oktay, et al.
Publicado: (2017) -
Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
por: Lee, John M., et al.
Publicado: (2019)